Ophthalmic Drugs: World Market Prospects 2012-2022

Posted: Published on May 2nd, 2012

This post was added by Dr P. Richardson

NEW YORK, May 2, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Ophthalmic Drugs: World Market Prospects 2012-2022

http://www.reportlinker.com/p0847305/Ophthalmic-Drugs-World-Market-Prospects-2012-2022.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication

Report Details

How to find trends and revenue predictions for the ophthalmic drug industry

What are the commercial prospects for treating eye disorders? Visiongain's report shows you potential revenues to 2022 - data, forecasts and discussions.

This study investigates prescription drugs treating human eye diseases. It lets you assess forecasted sales trends at world market, therapeutic submarket, product and national level to 2022.

How will 20 leading ophthalmic drugs - including Lucentis, Visudyne, Xalatan/Xalacom and Restasis - perform from 2012? Our investigation gives you business research and analysis with sales forecasts.

You also see forecasting of five submarkets to 2022, finding potential revenues:

Glaucoma treatments

Read more here:
Ophthalmic Drugs: World Market Prospects 2012-2022

Related Posts
This entry was posted in Drugs. Bookmark the permalink.

Comments are closed.